Celcuity, Inc. (CELC)
89.78
+1.54
(+1.75%)
USD |
NASDAQ |
Jun 11, 14:46
Celcuity 1 Year Total Returns (Daily) : 583.0% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 583.0% |
| June 09, 2026 | 617.2% |
| June 08, 2026 | 570.0% |
| June 05, 2026 | 649.4% |
| June 04, 2026 | 671.9% |
| June 03, 2026 | 645.0% |
| June 02, 2026 | 686.7% |
| June 01, 2026 | 1.06K% |
| May 29, 2026 | 1.13K% |
| May 28, 2026 | 1.15K% |
| May 27, 2026 | 1.17K% |
| May 26, 2026 | 1.19K% |
| May 22, 2026 | 1.19K% |
| May 21, 2026 | 1.24K% |
| May 20, 2026 | 1.22K% |
| May 19, 2026 | 1.13K% |
| May 18, 2026 | 1.15K% |
| May 15, 2026 | 1.21K% |
| May 14, 2026 | 1.14K% |
| May 13, 2026 | 1.05K% |
| May 12, 2026 | 1.07K% |
| May 11, 2026 | 1.14K% |
| May 08, 2026 | 1.14K% |
| May 07, 2026 | 1.18K% |
| May 06, 2026 | 1.28K% |
| Date | Value |
|---|---|
| May 05, 2026 | 1.21K% |
| May 04, 2026 | 1.23K% |
| May 01, 2026 | 1.06K% |
| April 30, 2026 | 989.3% |
| April 29, 2026 | 960.6% |
| April 28, 2026 | 982.7% |
| April 27, 2026 | 1.06K% |
| April 24, 2026 | 996.3% |
| April 23, 2026 | 925.8% |
| April 22, 2026 | 1.00K% |
| April 21, 2026 | 1.11K% |
| April 20, 2026 | 1.07K% |
| April 17, 2026 | 1.10K% |
| April 16, 2026 | 1.15K% |
| April 15, 2026 | 1.12K% |
| April 14, 2026 | 1.14K% |
| April 13, 2026 | 1.20K% |
| April 10, 2026 | 1.25K% |
| April 09, 2026 | 1.34K% |
| April 08, 2026 | 1.32K% |
| April 07, 2026 | 1.16K% |
| April 06, 2026 | 1.22K% |
| April 02, 2026 | 1.10K% |
| April 01, 2026 | 1.12K% |
| March 31, 2026 | 1.03K% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Revolution Medicines, Inc. | 243.5% |
| Tango Therapeutics, Inc. | 541.6% |
| Kymera Therapeutics, Inc. | 60.97% |
| Cogent Biosciences, Inc. | 322.9% |
| Erasca, Inc. | 730.4% |